TNFRSF8 and neoplasm: As our published and unpublished data indicate that the CD30 receptor is a potential player in tumor-induced immunosuppression, we focused our analysis on three miRs, namely miR-30c-5p, miR-23a-3p and miR-4299, which were predicted to target the TNFRSF8/CD30 gene as well as other genes in the gene network.